Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04926571 · ClinicalTrials.gov registry record
Dexamethasone and COVID-19 Inpatient Mortality
A clinical trial, sponsored by Aetion.
- Completed
- Registry status
- 14,105
- Enrollment target
NCT04926571 is a clinical trial that has completed, run by Aetion. The registered enrollment target is 14,105 participants.
The verdict
NCT04926571 has completed, sponsored by Aetion.
- COMPLETED
- Registry status
- 14,105 participants
- Enrollment target
Study Summary
The study aims to assess the effectiveness of dexamethasone initiation to reduce the risk of inpatient mortality within 28 days among US patients hospitalized with COVID-19 diagnosis or SARS-CoV-2 infection, overall and stratified by COVID-19 severity subgroups.
Interventions
- DRUG Dexamethasone Oral
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14,105 participants |
| Start Date | 2020-04-01 |
| Est. Completion | 2021-08-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04926571
The ClinicalTrials.gov registry entry for NCT04926571 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 14,105 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Aetion, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dexamethasone Oral is the first listed.
NCT04926571 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04926571 about?
NCT04926571 is a clinical study titled "Dexamethasone and COVID-19 Inpatient Mortality". The study aims to assess the effectiveness of dexamethasone initiation to reduce the risk of inpatient mortality within 28 days among US patients hospitalized with COVID-19 diagnosis or SARS-CoV-2 infection, overall and stratified by COVID-19 severity subgroups.
What is the current status of trial NCT04926571?
This trial is currently completed. The enrollment target is 14,105 participants. The study started on 2020-04-01. Estimated completion is 2021-08-27.
What interventions are being tested in trial NCT04926571?
The interventions under investigation include: Dexamethasone Oral (DRUG).
Who is sponsoring clinical trial NCT04926571?
This trial is sponsored by Aetion, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.